Doll Therapy for Apathy and Daily Living in Older Adults with Dementia
Official title: Effects of Doll Therapy on Apathy and Activities of Daily Living Initiation Deficits in Older Adults With Dementia: a Randomized Controlled Trial
Run by Guangzhou Medical University · NCT07907042 · Data updated 2026-11-12
This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 106 (estimated) |
| Sponsor | Guangzhou Medical University Academic / other |
| Locations | 1 site (Guangdong, Guangzhou) |
| Status | Recruiting |
| Started | August 10, 2026 |
| Main results expected | January 30, 2027 |
| Study ends | February 14, 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07907042 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Older adults (60+) with dementia, hospitalized for more than four weeks, and with AES-I scores indicating apathy.
✕Probably not a fit
Individuals who decline doll interaction, have severe sensory impairments not correctable, or have uncontrolled behavioral symptoms may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines the effect of guided doll therapy on apathy levels and initiation of basic activities of daily living in older adults with dementia. Participants are 60 years or older, diagnosed with Alzheimer's disease or other dementias, and have been hospitalized for more than four weeks with notable apathy. The primary goal is to see if doll therapy can reduce apathy; a secondary goal is to see if it improves initiation of daily activities such as dressing and personal care. The therapy involves structured interaction with dolls to promote emotional engagement and participation. Results from this trial may inform non-pharmacological approaches to maintaining daily functioning in dementia care.
Why it matters
Potential benefit: If successful, doll therapy could help patients initiate daily activities more independently and reduce caregiver burden.
How similar studies have gone: Prior studies suggest doll therapy can improve behavioral symptoms in dementia, but its effect on apathy and BADL initiation is less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 60 years or older. 2. Diagnosed with Alzheimer's disease or other types of dementia according to the International Classification of Diseases, 10th Revision (ICD-10), or with major neurocognitive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 3. Hospitalization duration exceeding 4 weeks. 4. Apathy Evaluation Scale-Informant Version (AES-I) score ≥33. 5. Not participating in any other clinical research trials. 6. Voluntary participation with written informed consent provided by the participant or their legally authorized representative. Exclusion Criteria: 1. Explicit refusal to interact with dolls. 2. Severe uncorrected hearing or visual impairment. 3. Uncontrolled severe behavioral and psychological symptoms (e.g., delusions or aggressive behavior) or a primary psychiatric disorder (e.g., schizophrenia or bipolar disorder). 4. Comorbid conditions that may impair the ability to independently perform personal hygiene activities, such as hemiplegia, paralysis, joint or skeletal disorders, or Parkinson's disease. 5. Presence of a terminal illness.
Where it's running
-
Guangzhou Geriatric Hospital
Guangdong, Guangzhou, China Recruiting
Study contacts
- Study coordinator: Xinyu Zhang
- Email: zxy0206cc@163.com
- Phone: 86+136-5229-6193
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.